DSN editor in chief Seth Mendelson takes a look at what Walgreens' plans to shutter 200 U.S. stores means for the chain amid continued reimbursement pressure.
Under the settlement, Par will market its generic Auryxia beginning on March 20, 2025, excepting certain circumstances that would lead to an earlier launch.
Mallinckrodt has suspended the spin-off of its specialty generics business, but it is still considering several options for splitting off the business, according to a recent Bloomberg report.
Pfizer and GlaxoSmithKline have closed their joint venture to combine their respective consumer healthcare businesses and form the world’s largest over-the-counter business. This new venture will operate as the new GSK Consumer Healthcare.
Pfizer is set to combine its off-patent and generics business with Mylan in an all-stock deal that will create a new company led by executives from both companies.
